A detailed history of Belpointe Asset Management LLC transactions in Novo Nordisk A S stock. As of the latest transaction made, Belpointe Asset Management LLC holds 11,334 shares of NVO stock, worth $944,575. This represents 0.09% of its overall portfolio holdings.

Number of Shares
11,334
Previous 3,085 267.39%
Holding current value
$944,575
Previous $440,000 206.59%
% of portfolio
0.09%
Previous 0.03%

Shares

13 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 12, 2024

BUY
$119.07 - $145.42 $982,208 - $1.2 Million
8,249 Added 267.39%
11,334 $1.35 Million
Q2 2024

Aug 02, 2024

BUY
$122.71 - $146.91 $14,602 - $17,482
119 Added 4.01%
3,085 $440,000
Q1 2024

May 08, 2024

BUY
$102.11 - $135.92 $71,681 - $95,415
702 Added 31.01%
2,966 $380,000
Q4 2023

Feb 13, 2024

BUY
$87.78 - $105.45 $2,808 - $3,374
32 Added 1.43%
2,264 $234,000
Q3 2023

Nov 15, 2023

BUY
$90.94 - $199.54 $45,379 - $99,570
499 Added 28.79%
2,232 $202,000
Q2 2023

Aug 14, 2023

SELL
$155.98 - $172.65 $321,006 - $355,313
-2,058 Reduced 54.29%
1,733 $280,000
Q1 2023

May 15, 2023

BUY
$132.34 - $159.14 $84,035 - $101,053
635 Added 20.12%
3,791 $603,000
Q4 2022

Feb 08, 2023

SELL
$102.55 - $135.33 $2,973 - $3,924
-29 Reduced 0.91%
3,156 $427,000
Q3 2022

Nov 14, 2022

BUY
$95.28 - $116.93 $153,019 - $187,789
1,606 Added 101.71%
3,185 $318,000
Q2 2022

Aug 02, 2022

BUY
$103.24 - $121.81 $43,360 - $51,160
420 Added 36.24%
1,579 $176,000
Q1 2022

Apr 28, 2022

BUY
$93.1 - $112.54 $107,902 - $130,433
1,159 New
1,159 $129,000
Q3 2021

Nov 15, 2021

SELL
$84.42 - $106.62 $111,434 - $140,738
-1,320 Closed
0 $0
Q2 2021

Aug 09, 2021

BUY
$67.66 - $84.76 $89,311 - $111,883
1,320 New
1,320 $111,000

Others Institutions Holding NVO

About NOVO NORDISK A S


  • Ticker NVO
  • Exchange OTC
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 2,257,289,984
  • Market Cap $188B
  • Description
  • Novo Nordisk A/S, a healthcare company, engages in the research, development, manufacture, and marketing of pharmaceutical products worldwide. It operates in two segments, Diabetes and Obesity care, and Biopharm. The Diabetes and Obesity care segment provides products in the areas of insulins, GLP-1 and related delivery systems, oral antidiabeti...
More about NVO
Track This Portfolio

Track Belpointe Asset Management LLC Portfolio

Follow Belpointe Asset Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Belpointe Asset Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Belpointe Asset Management LLC with notifications on news.